Novo Nordisk Researchers are Pushing the Boundaries of Science to Address Chronic Disease
Theresa Bak-Thomsen, PhD, Director, Discovery Biologics at Novo Nordisk research center Seattle discusses her path to becoming a woman in leadership/STEM. She talks about how her multifaceted team is exploring new modes of action to discover potential new therapies and provides insight into what it takes to discover and develop new antibodies for medical conditions. She also discusses the broader scientific focus of the Novo Nordisk research center Seattle – the foundation of the company’s U.S. research development efforts for diabetes, obesity, liver disease, and other therapeutic areas.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Diabetes. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Diabetes and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Diabetes?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Theresa Bak-Thomsen, Ph.D., is Director of Discovery Biologics at Novo Nordisk Research Center Seattle and brings with her a depth of experience in antibody discovery as well as a passion for the interplay between biology, technology, and drug discovery.
In her career, she has overseen and supported the discovery of potential treatments in a variety of therapeutic areas including diabetes, obesity, hemophilia, and autoimmune diseases.
Prior to this role, Theresa served in various positions at the Novo Nordisk headquarters in Denmark. Theresa holds a Ph.D. in immunology as well as a Master of Science from the University of Southern Denmark. She completed her post-doc training at Harvard Medical School.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
